PUBLISHER: IMARC | PRODUCT CODE: 1635894
PUBLISHER: IMARC | PRODUCT CODE: 1635894
The global electrophoresis equipment market size reached USD 2.0 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 3.0 Billion by 2033, exhibiting a growth rate (CAGR) of 4.37% during 2025-2033. The ongoing advancements in biotechnology, increased demand for personalized medicine, rising prevalence of genetic disorders, growing research activities, and expanding product applications in pharmaceuticals, diagnostics, and academic research institutions globally are some of the key factors supporting the market trends.
Electrophoresis equipment is a laboratory tool used to separate or purify molecules based on charge, size, and binding affinity. It is widely used to analyze large molecules, such as nucleic acids, plasmids, deoxyribonucleic acid (DNA), ribonucleic acid (RNA), proteins, and fragments of these macromolecules by passing an electric current from end to end. Electrophoresis equipment is manufactured using an electrophoretic chamber which consists of a hard plastic box or tank with a cathode at one end and an anode at the opposite end. It is used in various applications, including vaccines, antibody analysis, hemoglobinopathies, and drug quality control. As a result, electrophoresis equipment finds extensive applications in forensic investigation, molecular biology, genetics, and microbiological labs to identify source DNA and manipulate protein molecules.
A significant increase in research and development activities across the globe is creating a positive outlook for the market. Electrophoresis equipment is extensively helpful in the rising number of ongoing biological research projects and initiatives regarding novel medicine discovery. In line with this, the increasing complexities in the treatment of diseases, such as genetically transmitted diseases, cancer, and various disorders, are favoring the market growth. Moreover, the widespread product adoption in the pharmaceutical industry for quality control of various formulations by analyzing and identifying the drug content, studying DNA fragments, and testing antibiotics and vaccines are acting as another growth-inducing factor. Along with this, the increasing utilization of capillary electrophoresis in the process of microbial detection and separation is propelling the market growth. Additionally, the widespread adoption of capillary electrophoresis during the Covid-19 pandemic to develop a cost-effective identification approach for novel SARS-CoV-2 variants, allowing local facilities to test and track SARS-CoV-2 variations is providing an impetus to the market growth. Apart from this, the introduction of microfluidic electrophoresis platforms to polyacrylamide gel electrophoresis that offers highly promising results is facilitating the market growth. Furthermore, increasing approvals from the regulatory authorities and the launch of an immunotyping device used to detect and identify monoclonal proteins in serum and urine are positively influencing the market growth. Other factors, including extensive research and development (R&D) activities, improvements in the healthcare infrastructure and the implementation of various government initiatives regarding pharmaceutical products' quality control and process validation, are anticipated to drive the market growth.
Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report.